Talent Diagnostics

See how deep-tech companies are really built.

Decision‑ready talent intelligence for investors and talent teams.

Talent Diagnostics reveals the structural risks, talent dynamics, and execution challenges that don’t show up in pitch decks, press releases, or financial filings.

By combining Zeki’s talent dataset with workforce, financial, and competitive context, Talent Diagnostics delivers a complete organisational health check—fast, clear, and actionable.

Why Company Diagnostics?

Reveal Hidden Risks

Spot workforce misalignments, critical attrition, and weak applied experience in scaling teams—before they derail growth.

Talent Meets Financials

See how technical capability and innovation depth connect to financial performance and competitive positioning.

Decision-Ready Reports

Rapid, expert-authored PDF reports ready in two business days.

Broad Coverage, Deep Focus

Listed and unlisted companies, 10M+ individuals, 4,500 areas of expertise, 100+ deep-tech sectors, 30+ countries

Key Features

Talent Diagnostics

Trends & Breakouts

See: workforce growth projections, talent mix projections and revenue projections.

Focus

Including: key areas of hiring focus, levels of experience and specialisations, and levels of retention.

Historic Data

Monthly updates with 1-month lag. Time series back to 2010.

Intelligence Layer

Covering: competitor benchmarking, star technical performers at company and star go-to-market performers at company.

Talent Diagnostics Use Cases

Pre-investment

Get a data-driven view of execution capability and talent quality before you commit. Make go/no-go calls with insights on team strength and scale-up readiness.

Post-investment

Elevate portfolio performance with unmatched intelligence for talent acquisition and strategy, empowering your talent teams to build and scale faster.

On-Demand Reports

Receive expert-authored, company-level PDF reports within two working days.

Available as single reports or flexible monthly/quarterly subscriptions.

Want a clearer picture of the companies
you’re backing—or buying?